SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Denali Therapeutics Says AVLAYAH Wins 2026 Prix Galien USA Award

Denali Therapeutics said AVLAYAH (tividenofusp alfa-eknm), described as the first FDA-approved biologic specifically designed to cross the blood-brain barrier, won the award for Best Biotechnology Product.

DNLI

Related stories